Concentration of Risk
|12 Months Ended|
Nov. 30, 2018
|Risks and Uncertainties [Abstract]|
|CONCENTRATION OF RISK||CONCENTRATION OF RISK
Most of the Company’s products are sold to major drug and food chains merchandisers, and wholesale beauty-aids distributors throughout the United States and Canada.
During the fiscal years ended November 30, 2018 and 2017, certain customers each accounted for more than 5% of the Company’s net sales, as follows:
The loss of any one of these customers could have a material adverse effect on the Company’s earnings and financial position.
During the fiscal years November 30, 2018 and 2017, certain products within the Company’s product lines accounted for more than 10% of the Company’s net sales as follows:
The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef